United States · Bill · HR
H.R. 8167 (116th)
Coronavirus Testing Capacity Expansion Act
Introduced
4 September 2020
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Coronavirus Testing Capacity Expansion Act This bill requires the Department of Health and Human Services to directly reimburse laboratories for certain tests and related services during the COVID-19 (i.e., coronavirus disease 2019) emergency and expands the categories of laboratories eligible for certain COVID-19 relief funding. Specifically, veterinary and biotechnology company laboratories may receive federal COVID-19 funds for activities related to testing. Currently, this funding is limited to academic, commercial, public health, or hospital laboratories.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 4 September 2020
Introduced in House (PDF)
Introduced in House · EN · 4 September 2020
Introduced in House
summary · EN · 4 September 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/8167
- Open data entity: https://api.congress.gov/v3/bill/116/hr/8167